Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd. (GLMD) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · GLMD · as of Mar 31, 2023
Ownership Breakdown
21
Institutional Holders
$878,347
Total Inst. Value
▼ $335,701 vs Q4
5.48M
Shares Outstanding
freeFloat 98.81%
2.06M
13F Shares Held
▼ 364,223 vs Q4
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
GLMD largest shareholders · institutional ownership
Q1 2023 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
BVF INC/IL pharmaceutical preparations | 1.35M | 80.21% | 80.21% | $574.82M | May 15, 2023 | ▼ 391.9K |
MORGAN STANLEY pharmaceutical preparations | 204.2K | 12.16% | 12.16% | $87.11M | May 15, 2023 | ▲ 23.5K |
RAYMOND JAMES & ASSOCIATES pharmaceutical preparations | 138.0K | 8.22% | 8.22% | $58.87M | Apr 14, 2023 | — held |
MILLENNIUM MANAGEMENT LLC pharmaceutical preparations | 131.6K | 7.83% | 7.83% | $56.00M | May 15, 2023 | ▼ 17.6K |
CITADEL ADVISORS LLC pharmaceutical preparations | 40.8K | 2.43% | 2.43% | $17.42M | May 15, 2023 | ▲ 40.8K |
VIRTU FINANCIAL LLC pharmaceutical preparations | 31.6K | 1.88% | 1.88% | $13.00M | May 1, 2023 | ▲ 31.6K |
WESTERN WEALTH MANAGEMENT, LLC pharmaceutical preparations | 29.5K | 1.76% | 1.76% | $12.60M | Aug 30, 2023 | — held |
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. pharmaceutical preparations | 28.5K | 1.70% | 1.70% | $12.00M | May 11, 2023 | — held |
RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC. pharmaceutical preparations | 27.9K | 1.66% | 1.66% | $11.90M | Apr 14, 2023 | — held |
GEODE CAPITAL MANAGEMENT, LLC pharmaceutical preparations | 27.2K | 1.62% | 1.62% | $11.59M | May 15, 2023 | — held |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q1 2023 vs prior quarter
Q1 2023
4
Increased
+109.1K shares3
New Positions
first time holders4
Decreased
−440.7K shares7
Sold Out
fully exitedNet shares change (top 50)
331.5K
+109.1K / −440.7K
Net new holders
-4
3 new / 7 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
GLMD insider trading · insider activity
Source: SEC Form 4
Recent Insider Transactions
Showing 10 most recent · Common Stock only
No recent insider transactions reported.
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Galmed Pharmaceuticals Ltd. (GLMD) is primarily owned by institutional investors, who hold approximately 37.6% of total shares outstanding. Company insiders own approximately 1.19%, while retail and public investors account for the remaining 61.17%.
The largest institutional shareholder of Galmed Pharmaceuticals Ltd. is BVF INC/IL, holding approximately 1.35 million shares — equal to 80.21% of outstanding shares — as of March 31, 2023.
A total of 21 institutional investors currently hold GLMD stock, with a combined institutional value of approximately $878,347 as of the most recent 13F filing period.
Frequently asked questions
GLMD ownershipGalmed Pharmaceuticals Ltd. (GLMD) is primarily owned by institutional investors, who hold approximately 37.6% of shares. The largest shareholder is BVF INC/IL with a 80.21% stake. Company insiders hold 1.19%. Data sourced from SEC Form 13F as of March 31, 2023.